All In Biotech

Free tool

FAERS Monitor: Orgovyx

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 214621 or its brand name (Orgovyx, Relugolix). Reports on generic versions are filed under their own applications.

Reports

24,260

Serious

6,066

25% of reports

Hospitalization

2,257

Death reported

1,187

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • hot flush7,658
  • fatigue5,907
  • therapy interrupted3,381
  • incorrect dose administered2,129
  • asthenia1,977
  • arthralgia1,592
  • diarrhoea1,554
  • dizziness1,344
  • product dose omission issue1,338
  • constipation1,049
  • death1,005
  • weight increased894
  • pain867
  • insomnia853
  • myalgia824

Reports by year received

View as table
YearReports
20161
20171
20195
20203
2021472
20222,334
20232,979
20245,774
202510,315
20262,376

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,029,899 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
hot flushSignal7,65897.996.0662,429
therapy interruptedSignal3,38143.041.6132,559
incorrect dose administeredSignal2,1298.27.813,374
fatigueSignal5,9076.66.529,041
astheniaSignal1,9774.64.45,595
myalgiaSignal8244.23.92,026
constipationSignal1,0494.23.92,554
product dose omission issueSignal1,3384.03.82,983
weight increasedSignal8943.53.31,581
arthralgiaSignal1,5923.33.22,633
insomniaSignal8532.82.6981
dizzinessSignal1,3442.32.21,052
diarrhoeaSignal1,5542.12.0908
pain8671.21.136
death1,0051.01.00

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.